Abstract
ObjectiveLow molecular weight heparin (LMWH) is currently the most commonly used intravenous anticoagulant drugs, but the lack of point of care testing (POCT) limit its applications in patients with severe...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
